Apeloa A Earnings, Revenue Beat in Q3
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Apeloa Pharmaceutical Co Ltd (000739)
Apeloa Pharmaceutical Co Ltd stock price live, this page displays SZ 000739 stock exchange data. View the 000739 premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Apeloa Pharmaceutical Co Ltd real time stock price chart below.
What Is the Apeloa Pharmaceutical Co Ltd Stock Price Today?
The Apeloa Pharmaceutical Co Ltd stock price today is 14.62.
What Is the Stock Symbol for Apeloa Pharmaceutical Co Ltd?
The stock symbol for Apeloa Pharmaceutical Co Ltd is ""000739.""
What Stock Exchange Does Apeloa Pharmaceutical Co Ltd Trade On?
Apeloa Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Apeloa Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Apeloa Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 000739 quote. (ISIN: CNE000000Q45)
What Is the Apeloa Pharmaceutical Co Ltd Stock Price Today?
The Apeloa Pharmaceutical Co Ltd stock price today is 14.62.
What Is the Stock Symbol for Apeloa Pharmaceutical Co Ltd?
The stock symbol for Apeloa Pharmaceutical Co Ltd is ""000739.""
What Stock Exchange Does Apeloa Pharmaceutical Co Ltd Trade On?
Apeloa Pharmaceutical Co Ltd is listed and trades on the Shenzhen stock exchange.
Is Apeloa Pharmaceutical Co Ltd a Good Stock to Buy?
Determining whether Apeloa Pharmaceutical Co Ltd—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the 000739 quote. (ISIN: CNE000000Q45)
Shenzhen
Currency in CNY
14.62
+0.01(+0.07%)
Delayed Data·
Fair Value
An estimate of a Apeloa A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.56
14.69
52 wk Range
12.96
18.96
000739 Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
000739 is not included in our AI-picked strategies. See which stocks are.
Review Strategies
Fair Value
An estimate of a Apeloa A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
14.5614.69
52 wk Range
12.9618.96
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.44%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.44%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
000739 Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Apeloa A's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Analysts Sentiment
Strong Buy
Price Target
19.43
Upside
+32.87%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Has raised its dividend for 7 consecutive years
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Neutral
Technical Indicators
Strong Sell
Moving Averages
Buy
Apeloa Pharmaceutical Co Ltd Company Profile
Apeloa Pharmaceutical Co.,Ltd provides raw materials and intermediates to various pharmaceutical factories in the People’s Republic of China and internationally. The company offers preparation products, including cardio-cerebrovascular, anti-infection, anti-tumor, anti-viral, and special drugs. It offers its products under the Tianliwei, Beshin, Yosemade, Jutai, and other brands. Apeloa Pharmaceutical Co.,Ltd was founded in 1989 and is based in Dongyang, the People’s Republic of China.
Compare 000739 to Peers and Sector
Metrics to compare | 000739 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship000739PeersSector | |
|---|---|---|---|---|
P/E Ratio | 16.4x | 28.7x | −0.5x | |
PEG Ratio | −9.44 | −0.99 | 0.00 | |
Price/Book | 2.4x | 2.9x | 2.6x | |
Price / LTM Sales | 1.5x | 3.2x | 3.2x | |
Upside (Analyst Target) | 34.5% | 11.6% | 45.3% | |
Fair Value Upside | Unlock | 5.4% | 7.4% | Unlock |
Analyst Ratings
7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 19.43
(+32.87% Upside)
Earnings
Latest Release
Apr 22, 2025
EPS / Forecast
0.34 / 0.34
Revenue / Forecast
2.73B / --
People Also Watch
FAQ
What Stock Exchange Does Apeloa A Trade On?
Apeloa A is listed and trades on the Shenzhen Stock Exchange stock exchange.
What Is the Stock Symbol for Apeloa A?
The stock symbol for Apeloa A is "000739."
What Is the Apeloa A Market Cap?
As of today, Apeloa A market cap is 16.92B.
What Is Apeloa A's Earnings Per Share (TTM)?
The Apeloa A EPS (TTM) is 0.89.
When Is the Next Apeloa A Earnings Date?
Apeloa A will release its next earnings report on 19 Aug 2025.
From a Technical Analysis Perspective, Is 000739 a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Apeloa A Stock Split?
Apeloa A has split 6 times.
How Many Employees Does Apeloa A Have?
Apeloa A has 7060 employees.
What is the current trading status of Apeloa A (000739)?
As of 16 Jul 2025, Apeloa A (000739) is trading at a price of 14.62, with a previous close of 14.61. The stock has fluctuated within a day range of 14.56 to 14.69, while its 52-week range spans from 12.96 to 18.96.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.